SMA Centennial

A Historical Look at Hypertension: Celebrating 100 Years with the Southern Medical Association

Authors: Jan N. Basile, MD, Hector Ventura, MD

Abstract

As the Southern Medical Association (SMA) celebrates its 100th year anniversary, it is appropriate to look back on how the Southern Medical Journal (SMJ) has influenced the diagnosis and treatment of hypertension over the past century.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Nei Ching Yellow Emperor's Classic of Internal Medicine. Books 2–9, published between 2698 and 2598 B.C.
 
2. Hales S. Statistical Essays: Containing Hemostatics. London, Innys and Manhy, 1933.
 
3. Riva-Rocci S. Gaza Med Torino 1896;47:981–1001.
 
4. Korotkoff NS. Izvestiya Imperatorskoi Voenno-Meditsinskoy Akadernii. Rep ImperMIL-med Acca St Peterburg. 1905;11:365–367.
 
5. Freis ED. Chapter 164. In: Laragh JH, Brenner BM (eds). Hypertension, Pathophysiology Diagnosis and Management, 2nd ed. New York, Raven Press, pp 2741–2751.
 
6. Strickler CW. Significance of Hypertension. South Med J 1917;10:191–194.
 
7. Bruenn HG. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med 1970;72:579–591.
 
8. Roberts SR. Hypertension. J Med Assoc Georgia 1936;25:413–417.
 
9. Moser M. Evolution of the treatment of hypertension from the 1940s to JNV V. Am J Hypertens1997;10:2S–10S.
 
10. Freis ED, Wanko A, Wilson IM, et al. Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. J Am Med Assoc 1958;166:137–140.
 
11. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143–1152.
 
12. Freis ED. Treatment of Hypertension. Southern Medical Journal 1958;58:1281–288.
 
13. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA 1977;237:255–261.
 
14. Chobanian A, Bakris G, Black H, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA2003;289:2560–2572.
 
15. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413–2446.
 
16. Basile JN. Hypertension 2001: pearls for the clinician. South Med J 2001;94:1054–1057.
 
17. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;2981–2997.
 
18. Weir MR. When antihypertensive monotherapy fails: fixed-dose combination therapy. South Med J2000;93:548–556.
 
19. Fields L, Burt V, Cutler J, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398–404.
 
20. Hajjar I, Kotchen T. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199–206.